The many modes of meta

Drug Information Journal

Volumn 34, Issue 2, 2000, Pages 535-549

  Senn, Stephen ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Fixed effects; Meta analysis; Multicenter trials; N of 1 trials; Random effects

Indexed keywords

CLINICAL TRIAL; DATA ANALYSIS; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 0034123425     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150003400222     Document Type: Review

References (49)

1. Senn SJ. Statistical Issues in Drug Development. Chichester, UK: Wiley; 1997.
2. Petitti DB. Meta-analysis Decision Analysis and Cost-Effectiveness Analysis. Oxford, UK: Oxford; 1994.
3. Glass GV. Primary, secondary and meta-analysis of research. Ed Res. 1976;5:3-8.
4. Pearson K. Report on certain enteric fever inoculation statistics. Br Med J. 1904; Nov 5: 1243-1246.
5. Winkelstein W. The first use of meta-analysis? Am J Epid. 1998;147:717.
6. Fisher RA. Studies in crop variation. J Agric Sci. 1921;11:107-135.
7. Healy MJR. Frank Yates, 1902-1994 - The work of a statistician. Int Stat Rev. 1995;63:271-288.
8. Yates F, Cochran WG. The analysis of groups of experiments. J Agr Sci. 1938;28:556-580.
9. Tippett LHG. The Methods of Statistics. London, UK: Williams and Norgate; 1931.
10. Fisher RA. Statistical Methods for Research Workers. 4th edition. Edinburgh, UK: Oliver and Boyd; 1932.
11. Sonneman E. Kombination unabhängiger tests. In: Vollmar, J ed. Biometrie in der chemische pharmazeutischen Industrie 4. Stuttgart, Germany: Fischer; 1991:91-112.
12. Peto R. Why do we need systematic overviews of randomized trials? (With discussion) Stat Med. 1987; 6:233-240.
13. Egger M, Davey Smith G. Bias in location and selection of studies. Br Med J. 1998;316:61-66.
14. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epid. 2000.
15. Eysenck H. Meta-analysis and its problems. Br Med J. 1994;309:789-792.
16. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses. Lancet. 1998;352:609-613.
17. Lee PN. Simple methods for checking for possible errors in reported odds ratios, relative risks and confidence intervals. Stat Med. 1999;18:1973-1981.
18. Stewart LA, Parmar MK. Meta-analysis of the literature or of individual data: is there a difference? Lancet. 1993;341:418-422.
19. Light RJ. Accumulating evidence from independent studies: what we can win and what we can lose. Stat Med. 1987;6:221-228.
20. Thompson SG, Pocock, SJ. Can meta-analysis be trusted? Lancet. 1991;338,1127-1130.
21. Lindbaeck M, Hjortdahl P. How do two meta-analyses of similar data reach opposite conclusions? Br Med J. 1999;318:873.
22. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Statistical principles for clinical trials. Stat Med. 1999;18:1905-1942.
23. Richardson W, Bablok, B. Clinical experience with formoterol. In Holgate, ST, Ed. Formoterol: Fast and Long-Lasting Brochodilation. London, UK: Royal Society of Medicine Services; 1992.
24. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst. 1959;22:719-748.
25. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomised clinical trials. Stat Med. 1991;31:1665-1677.
26. Hedges LV, Olkin I. Statistical Methods for Meta-analysis. Orlando, Florida: Academic Press; 1985.
27. Salsburg, D. Why analysis of variance is inappropriate for multiclinic trials. Cont Clin Trials. 1999;20: 453-468.
28. Senn SJ, Harrell F. On wisdom after the event. J Clin Epidemiol. 1997;50:749-751.
29. Goldstein H. Multilevel Models in Educational and Social Research. London, UK: Griffin; 1987.
30. Källén A. Treatment-by-center interaction: what is the issue? Drug Inf J. 1997;31:927-936.
31. Gallo P. Center-Weighting Issues in Multicenter Clinical Trials. J Biopharm Stats. 2000; 10.
32. Nelder J. A reformulation of linear models. (With discussion) J R Statist Soc A. 1977;140:48-77.
33. DerSimonian R Laird N. Meta-analysis in clinical trials. Cont Clin Trials. 1986;7:177-188.
34. Hardy RJ, Thompson SG. A likelihood approach to meta-analysis with random effects. Stat Med. 1996; 15:619-629.
35. Brand R, Kragt H. Importance of trends in the interpretation of an overall odds ratio in a meta-anlysis of clinical trials. Stat Med. 1992;11:2077-2082.
36. McIntosh M. The population risk as an explanatory variable in research synthesis of clinical trials. Stat Med. 1996;15:1713-1728.
37. Schmid CH. Exploring heterogeneity in randomized trials via meta-analysis. Drug Inf J. 1999;33:211-224.
38. Senn SJ. Importance of trends in the interpretation of an overall odds-ratio in a meta-analysis of clinical trials. Stat Med. 1994;13:293-295.
39. Van Houwelingen H, Senn SJ. Letter to the editor: Investigating underlying risk as a source of heterogeniety in meta-analysis. Stat Med. 1999;18:110-113.
40. Van Houwelingen H, Zwinderman K, Stijnen T. A bivariate approach to meta-analysis. Stat Med. 1993; 12:2272-2284.
41. Thompson SG, Smith TC, Sharp SJ. Investigating underlying risk as a source of heterogeneity in meta-analysis. Stat Med. 1997;16:2883-2900.
42. Thompson SG, Prevost TC, Sharp SJ. Authors' reply. Stat Med. 1999;18:113-115.
43. Neider, J. The statistics of linear models: back to basics. Statist Comp. 1994;4:221-234.
44. Chuang-Stein C, Tong D. The impact of parameterization on the interpretation of the main-effect term in th; presence of an interaction. Drug lnf J. 1996; 30:421-424.
45. Speed FM, Hocking RR, Hackney OP. Methods of analysis of linear models with unbalanced data. J Am Stat Assoc. 1978;73:105-112.
46. Jeffreys. Theory of Probability. Oxford, UK: Clarendon Press; 1939.
47. Fisher RA. Statistical Methods for Research Workers. In Bennett, Ed. Statistical Methods, Experimental Design and Scientific Inference. Oxford, UK: Oxford Science Publications; 1990.
48. Berry DA. A case for Bayesianism in clinical trials (with discussion). Stat Med. 1993;12:1377-1404.
49. Smith TC, Spiegelhalter DJ, Parmar MKB. Bayesian meta-analysis of randomized trials using graphical models and BUGS. In: Berry DA and Stangl DK, eds. Bayesian Biostatistics. New York, NY. Marcel Dekker; 1996.